Literature DB >> 25857231

Organic anion transporting polypeptide 2B1 expression correlates with uptake of estrone-3-sulfate and cell proliferation in estrogen receptor-positive breast cancer cells.

Jun Matsumoto1, Noritaka Ariyoshi2, Masahiro Sakakibara3, Takeo Nakanishi4, Yoshiyuki Okubo3, Nobumitsu Shiina3, Kaoru Fujisaki3, Takeshi Nagashima3, Yukio Nakatani5, Ikumi Tamai4, Harumi Yamada6, Hiroshi Takeda6, Itsuko Ishii7.   

Abstract

Estrone-3-sulfate (E1S) is thought to be a major estrogen precursor in estrogen receptor (ER)-positive breast cancer. Since E1S is a hydrophilic compound, the uptake of E1S into cancer cells is probably mediated by transporters, such as organic anion-transporting polypeptide (OATP, SLCO) family. In this study, we investigated the relationship between expression of OATP2B1 and cell proliferation in ER-positive breast cancer. Cell-based assays were carried out in MCF-7 cells both with and without overexpression of OATP2B1. Normal breast and tumor tissues were collected and used in this study. Cell proliferation, ER-mediated transcriptional activities and estradiol secretion were stimulated by addition of E1S to the culture medium of MCF-7 cells. These stimulatory effects were significantly greater in MCF-7 cells overexpressing OATP2B1 than in control cells. The expression level of SLCO2B1 mRNA was significantly correlated with histological grade, Ki-67 labelling index and mRNA expression of steroid sulfatase. The expression level of SLCO2B1 mRNA in luminal B-like cancers was higher than that in luminal A-like cancers. Uptake of E1S resulted in down-regulation of ERα protein and induction of Ki-67 in MCF-7 cells. The present study suggests that OATP2B1 is involved in cell proliferation by increasing the amount of estrogen in ER-positive breast cancer cells.
Copyright © 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Estrogen receptor; Estrone-3-sulfate; Ki-67; Luminal A-like; Luminal B-Like; Organic anion-transporting polypeptide 2B1

Mesh:

Substances:

Year:  2014        PMID: 25857231     DOI: 10.1016/j.dmpk.2014.10.005

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  7 in total

Review 1.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

Review 2.  Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology.

Authors:  Rachael R Schulte; Richard H Ho
Journal:  Mol Pharmacol       Date:  2019-02-19       Impact factor: 4.436

3.  Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer.

Authors:  Martin Svoboda; Felicitas Mungenast; Andreas Gleiss; Ignace Vergote; Adriaan Vanderstichele; Jalid Sehouli; Elena Braicu; Sven Mahner; Walter Jäger; Diana Mechtcheriakova; Dan Cacsire-Tong; Robert Zeillinger; Theresia Thalhammer; Dietmar Pils
Journal:  Front Pharmacol       Date:  2018-08-07       Impact factor: 5.810

4.  Pd-Catalyzed microwave-assisted synthesis of phosphonated 13α-estrones as potential OATP2B1, 17β-HSD1 and/or STS inhibitors.

Authors:  Rebeka Jójárt; Szabolcs Pécsy; György Keglevich; Mihály Szécsi; Réka Rigó; Csilla Özvegy-Laczka; Gábor Kecskeméti; Erzsébet Mernyák
Journal:  Beilstein J Org Chem       Date:  2018-11-14       Impact factor: 2.883

5.  Finding associations in a heterogeneous setting: statistical test for aberration enrichment.

Authors:  Aziz M Mezlini; Sudeshna Das; Anna Goldenberg
Journal:  Genome Med       Date:  2021-04-23       Impact factor: 11.117

6.  Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6).

Authors:  Emre Karakus; Daniel Zahner; Gary Grosser; Regina Leidolf; Cemal Gundogdu; Alberto Sánchez-Guijo; Stefan A Wudy; Joachim Geyer
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

7.  Synthesis and evaluation of anticancer activities of 2- or 4-substituted 3-(N-benzyltriazolylmethyl)-13α-oestrone derivatives.

Authors:  Rebeka Jójárt; Seyyed Ashkan Senobar Tahaei; Péter Trungel-Nagy; Zoltán Kele; Renáta Minorics; Gábor Paragi; István Zupkó; Erzsébet Mernyák
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.